• Xpovio Open to Advanced Myeloma Patients Outside US via Access Program
  • C4 Therapeutics Readying to Open Phase 1/2a Trial of CFT7455
  • Blood Type O Lowers Myeloma Risk, But Outcomes Typically Worse
  • Darzalex Combos Linked to Stronger Cancer Eradication, Prolonged Survival
  • Xpovio Approved in Israel for Some Myeloma, Lymphoma Patients
  • FDA Clears Way for Clinical Trial of HDP-101
  • Under-the-skin Velcade Found to Work Better in Farydak Triple Combo
  • Phase 3 Trial of ATG-010 (Xpovio) for Advanced Myeloma Opens in China
  • EMA Plans Speedy Review of Cilta-cel, CAR T-cell Therapy for Advanced Myeloma
  • EU Committee Supports Nexpovio for Heavily Treated Myeloma Patients
  • Dosing Begins in Phase 1 Trial of CERC-007
  • Jakafi Plus Steroid Continuing to Treat Multiple Myeloma in Phase 1 Trial